Shopping Cart
- Remove All
- Your shopping cart is currently empty
Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue properties
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $817 | 1-2 weeks |
Description | Galnon is a galanin receptor agonist, improves intrinsic cortical bone tissue properties |
In vivo | Galnon has been characterized to inhibit seizures, decrease feeding behaviour, diminish physical signs of opiate withdrawal and to alleviate heat-hyperalgesic response to partial sciatic nerve injury[1]. Galnon, a GAL receptor agonist, may enhance osteoclastic bone resorption in OVX rats. Although galnon reduced bone volume, biomechanical testing revealed that bone of galnon-treated animals was mechanically superior per unit area. Taken together, galnon simultaneously improves the intrinsic quality of cortical bone whilst stimulating osteoclastic activity in the OVX rat model[2]. |
Molecular Weight | 678.82 |
Formula | C40H46N4O6 |
Cas No. | 475115-35-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.